Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of olivia. olivia is an AI-enabled ...

For example, a patient with a congenital heart condition can get the immediate ... Precision medicine company Tempus AI, which uses artificial intelligence to process medical data, announced ...

DeepSeek, a Chinese AI company, has emerged as a formidable player in the artificial intelligence landscape, particularly ...

The Philips Emergency Care Business plays a vital role in addressing sudden cardiac arrest (SCA ... Philips offers rugged, compact monitor-defibrillators like Tempus, equipped with vital sign ...

Bridgefield Capital, a private investment firm specializing in corporate carve-outs and special situations, announced today that it has entered into a definitive agreement to acquire the Philips ...

February is heart month, and technology is making it easier to self-monitor heart health. About one in five Americans use a ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

The majority of U.S. adults use a device on a regular basis to monitor their heart health, but only one in four uses those ...

Advances in technology have made it increasingly easier for people to self-monitor their heart health whether it's via a ...

Find out more about how we test. The Polar H10 heart rate monitor first launched in 2017 and has become known as one of the best heart monitors on the market, thanks to its accuracy and ease of use.

Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 24 trades. If we consider the specifics ...